Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -24.57% is 14% above its 5-year average of -28.53%, near the high end of its 5-year range (-40.64%–-20.34%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.05% below its 12-month average of -24.31%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-06-30): -24.57%.
RETURN ON INVESTED CAPITAL (ROIC)
-24.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-24.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-31.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-28.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-1.05%
CURRENT VS 3Y AVG
+20.98%
CURRENT VS 5Y AVG
+13.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+31.11%
vs the sector median at left
Twist Bioscience Corporation
Market Cap
$10.40B
Return on Invested Capital (ROIC)
-24.57%
TTM Avg
-24.31%
3Y Avg
-31.09%
5Y Avg
-28.53%
Market Cap
$10.31B
Return on Invested Capital (ROIC)
10.49%
TTM Avg
5.87%
3Y Avg
5.79%
5Y Avg
6.13%
Market Cap
$10.24B
Return on Invested Capital (ROIC)
-9.57%
TTM Avg
-18.31%
3Y Avg
-21.75%
5Y Avg
-17.22%
Market Cap
$10.19B
Return on Invested Capital (ROIC)
3.56%
TTM Avg
12.01%
3Y Avg
15.07%
5Y Avg
15.28%
Market Cap
$10.15B
Return on Invested Capital (ROIC)
-45.63%
TTM Avg
-80.95%
3Y Avg
-90.71%
5Y Avg
-98.29%
Market Cap
$10.13B
Return on Invested Capital (ROIC)
8.90%
TTM Avg
10.00%
3Y Avg
10.19%
5Y Avg
11.72%
Market Cap
$10.72B
Return on Invested Capital (ROIC)
11.74%
TTM Avg
10.95%
3Y Avg
8.97%
5Y Avg
9.05%
Market Cap
$10.03B
Return on Invested Capital (ROIC)
7.29%
TTM Avg
7.04%
3Y Avg
6.95%
5Y Avg
7.54%
Market Cap
$10.87B
Return on Invested Capital (ROIC)
1.40%
TTM Avg
5.80%
3Y Avg
4.23%
5Y Avg
2.43%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.40B | -24.57% | -24.31% | -31.09% | -28.53% |
| Globus Medical, Inc. (GMED)vs › | $10.31B | 10.49% | 5.87% | 5.79% | 6.13% |
| 10x Genomics, Inc. (TXG)vs › | $10.24B | -9.57% | -18.31% | -21.75% | -17.22% |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | 3.56% | 12.01% | 15.07% | 15.28% |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | -45.63% | -80.95% | -90.71% | -98.29% |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 8.90% | 10.00% | 10.19% | 11.72% |
| Universal Health Services, Inc. (UHS)vs › | $10.72B | 11.74% | 10.95% | 8.97% | 9.05% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 7.29% | 7.04% | 6.95% | 7.54% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | 1.40% | 5.80% | 4.23% | 2.43% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 1.54% | 2.53% | 2.92% | 2.77% |
ROIC
-24.6%
ROE
-30.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -24.57% |
| 2026-03-31 | -23.66% |
| 2025-12-31 | -23.60% |
| 2025-09-30 | -24.15% |
| 2025-06-30 | -25.58% |
| 2025-03-31 | -38.64% |
| 2024-12-31 | -38.69% |
| 2024-09-30 | -40.64% |
| 2024-06-30 | -40.58% |
| 2024-03-31 | -31.81% |
| 2023-12-31 | -32.17% |
| 2023-09-30 | -30.25% |
| 2023-06-30 | -29.83% |
| 2023-03-31 | -28.21% |
| 2022-12-31 | -26.59% |
| 2022-09-30 | -26.55% |
| 2022-06-30 | -24.15% |
| 2022-03-31 | -21.20% |
| 2021-12-31 | -24.47% |
| 2021-09-30 | -23.54% |
| 2021-06-30 | -20.34% |
| 2021-03-31 | -19.21% |
| 2020-12-31 | -17.58% |
| 2020-09-30 | -38.25% |
| 2020-06-30 | -38.17% |
| 2020-03-31 | -48.43% |
| 2019-12-31 | -102.92% |
| 2019-09-30 | -68.04% |
| 2019-06-30 | -52.51% |
| 2019-03-31 | -69.12% |
| 2018-12-31 | -51.55% |
| 2018-09-30 | -70.73% |
| 2018-06-30 | -63.51% |
